Frontlight ResearchEarly access
Trial site
Tokyo-Eki Center-building Clinic
- 4running trials
- 9closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Obesity7 trials
- Asthma1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Status
- Completed8 trials
- Recruiting3 trials
- Active, not recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
- Pfizer3 trials
- Upstream Bio Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Withdrawn
Completed
Completed
Completed
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 17 Nov 2026